| Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ... Movement disorders 32 (6), 853-864, 2017 | 2475 | 2017 |
| Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease O Preische, SA Schultz, A Apel, J Kuhle, SA Kaeser, C Barro, S Gräber, ... Nature medicine 25 (2), 277-283, 2019 | 987 | 2019 |
| Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study BA Gordon, TM Blazey, Y Su, A Hari-Raj, A Dincer, S Flores, ... The Lancet Neurology 17 (3), 241-250, 2018 | 695 | 2018 |
| A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease NR Barthélemy, Y Li, N Joseph-Mathurin, BA Gordon, J Hassenstab, ... Nature medicine 26 (3), 398-407, 2020 | 668 | 2020 |
| Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease J Wagner, S Ryazanov, A Leonov, J Levin, S Shi, F Schmidt, C Prix, ... Acta neuropathologica 125 (6), 795-813, 2013 | 533 | 2013 |
| Hough-CNN: Deep learning for segmentation of deep brain regions in MRI and ultrasound F Milletari, SA Ahmadi, C Kroll, A Plate, V Rozanski, J Maiostre, J Levin, ... Computer Vision and Image Understanding 164, 92-102, 2017 | 512 | 2017 |
| Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study KM Moore, J Nicholas, M Grossman, CT McMillan, DJ Irwin, L Massimo, ... The Lancet Neurology 19 (2), 145-156, 2020 | 370 | 2020 |
| The differential diagnosis and treatment of atypical parkinsonism J Levin, A Kurz, T Arzberger, A Giese, GU Höglinger Deutsches Ärzteblatt International 113 (5), 61, 2016 | 359 | 2016 |
| Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease E McDade, G Wang, BA Gordon, J Hassenstab, TLS Benzinger, V Buckles, ... Neurology 91 (14), e1295-e1306, 2018 | 348 | 2018 |
| Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds M Caruana, T Högen, J Levin, A Hillmer, A Giese, N Vassallo FEBS letters 585 (8), 1113-1120, 2011 | 326 | 2011 |
| Early changes in CSF sTREM2 in dominantly inherited Alzheimer’s disease occur after amyloid deposition and neuronal injury M Suárez-Calvet, MÁ Araque Caballero, G Kleinberger, RJ Bateman, ... Science translational medicine 8 (369), 369ra178-369ra178, 2016 | 315 | 2016 |
| Single particle characterization of iron-induced pore-forming α-synuclein oligomers M Kostka, T Hoegen, KM Danzer, J Levin, M Habeck, A Wirth, R Wagner, ... Journal of Biological Chemistry 283 (16), 10992-11003, 2008 | 308 | 2008 |
| Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology M Suárez-Calvet, E Morenas-Rodríguez, G Kleinberger, K Schlepckow, ... Molecular neurodegeneration 14 (1), 1, 2019 | 287 | 2019 |
| Assessment of 18F-PI-2620 as a biomarker in progressive supranuclear palsy M Brendel, H Barthel, T van Eimeren, K Marek, L Beyer, M Song, C Palleis, ... JAMA neurology 77 (11), 1408-1419, 2020 | 257 | 2020 |
| Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases X Xiang, K Wind, T Wiedemann, T Blume, Y Shi, N Briel, L Beyer, ... Science translational medicine 13 (615), eabe5640, 2021 | 255 | 2021 |
| Four-repeat tauopathies TW Rösler, AT Marvian, M Brendel, NP Nykänen, M Höllerhage, ... Progress in neurobiology 180, 101644, 2019 | 245 | 2019 |
| Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation M Kunadt, K Eckermann, A Stuendl, J Gong, B Russo, K Strauss, S Rai, ... Acta neuropathologica 129 (5), 695-713, 2015 | 223 | 2015 |
| Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study EL Van Der Ende, LH Meeter, JM Poos, JL Panman, LC Jiskoot, ... The Lancet Neurology 18 (12), 1103-1111, 2019 | 206 | 2019 |
| Which ante mortem clinical features predict progressive supranuclear palsy pathology? G Respondek, C Kurz, T Arzberger, Y Compta, E Englund, LW Ferguson, ... Movement Disorders 32 (7), 995-1005, 2017 | 204 | 2017 |
| First symptom in sporadic Creutzfeldt–Jakob disease GD Rabinovici, PN Wang, J Levin, L Cook, M Pravdin, J Davis, ... Neurology 66 (2), 286-287, 2006 | 197 | 2006 |
Armin GieseCSO, MODAG GmbHVerified email at modag.net
